scispace - formally typeset
Open AccessJournal ArticleDOI

Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy.

Chikako Ogawa, +2 more
- 01 Sep 2011 - 
- Vol. 7, Iss: 3, pp 180-197
TLDR
The structural modifications of MDP and its derivatives have been extensively studied in an attempt to increase adjuvant activity and boost the immune response effectively for clinical use in the treatment of cancer and other diseases.
Abstract
Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. It was first identified in bacterial cell wall peptidoglycan as an active component in Freund's complete adjuvant. In the cell, MDP is detected by NOD2, a cytoplasmic receptor belonging to the human innate immune system. NOD2 mutations are frequently observed in patients with Crohn's disease, an autoimmune disorder, suggesting the significance of the MDP-NOD2 pathway in activating immunity. For this reason, structural modifications of MDP and its derivatives have been extensively studied in an attempt to increase adjuvant activity and boost the immune response effectively for clinical use in the treatment of cancer and other diseases. This review summarizes the synthetic chemistry of MDP and its derivatives and discusses their pharmacological action and stereoselective synthesis.

read more

Content maybe subject to copyright    Report

Citations
More filters
Dissertation

Mass Spectrometry Methods for Enhanced Characterization of Biological Systems

TL;DR: In this paper, the authors describe the implementation of mass spectrometry (MS)-based methods in three areas where MS is well-positioned to fulfill unmet analytical needs: time-resolved electrospray ionization hydrogen-deuterium exchange (TRESI-HDX) and ion mobility spectroscopy (IMS)-MS were used to study conformational dynamics in transient C-lipid interactions.
Journal ArticleDOI

Design and Synthesis of Immunostimulating Mannosylated Muropeptide Analogs Containing 2-Aminoadamantane-2-carboxylic Acid

TL;DR: The design and synthesis of novel mannosylated muropeptide analogs containing 2-aminoadamantane-2-carboxylic acid are presented and Immunostimulating activities of prepared compounds will be evaluated in the mice model using ovalbumin as an antigen and compared with previously prepared derivatives.
Patent

Novel muramyl peptide derivative compound, synthesis and uses thereof

TL;DR: In this article, the Muramyl Dipeptide (MDP) derivative compound of structural Formula-VIII, a process for synthesis, intermediates used in the synthesis and use thereof.
References
More filters
Journal ArticleDOI

Inflammatory bowel disease: Etiology and pathogenesis

TL;DR: No single agent or distinct mechanism is the sine qua non motive that explains all aspects of IBD, and several distinguishing factors are likely necessary to result in either CD or UC; this review will attempt to discuss those that currently appear important.
Journal ArticleDOI

Peptidoglycan structure and architecture

TL;DR: In several species examined, the fine structure of the peptidoglycan significantly varies with the growth conditions, and the different models for the architecture are discussed with respect to structural and physical parameters.
Journal ArticleDOI

The immunological and genetic basis of inflammatory bowel disease.

TL;DR: The most important finding is the identification of mutations in the gene that encodes NOD2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.
Journal ArticleDOI

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

TL;DR: It is shown that protective immunity mediated by Nod2 recognition of bacterial muramyl dipeptide is abolished in Nod1-deficient mice, providing a possible mechanism for Nod 2 mutations in CD.
Related Papers (5)